Investor Relations

Learn More Vertical Image Vertical Blue Arrow Image
Scroll to learn more

Saagar Govil is honored as “40 Under Forty” by Stony Brook University

FARMINGDALE, N.Y. — Cemtrex Inc. (OTC:CTEI) — Saagar Govil, Chairman and CEO of Cemtrex Inc was honored with Top 40 Under Forty Award by Stony Brook University Alumni Association. Stony Brook honored its top 40 alumni under forty years of age who are the brightest, most innovative and entrepreneurial-spirited graduates. These individuals have demonstrated achievements in business, research, technology, the arts, leadership, entrepreneurial or philanthropic endeavors and exemplify the spirit of Stony Brook, including commitment, passion, leadership and the pursuit of excellence.

The awards were presented by the University President at a gala event in New York City on December 2, 2014, and Saagar Govil was among one of the youngest in the group of honorees. Other honorees included: Christopher Algieri, 2014 World Boxing Junior Welter Weight Champion; Joe Nathan, MLB Pitcher for Detroit Tigers; Neena Nadkarni, Head of Mobile Commerce at Google; Robert Calarco, Suffolk County Legislature; Ron Douglas Duckett, NY Times Best Selling Author; and Peter Kingham, Attending Surgeon at Sloan-Kettering Cancer Center.

“I am very pleased with this honor and extremely humbled to be recognized alongside such highly accomplished individuals from around the globe,” said Saagar Govil, “ this award has strengthened my resolve to build Cemtrex into a major company that will bring tremendous value to its shareholders.” continued Mr. Govil.

About Cemtrex, Inc.

Cemtrex, Inc. (CTEI) is a diversified technology company that provides a wide array of solutions to meet today’s industrial challenges. Cemtrex, through its wholly owned subsidiaries, provides electronic manufacturing services of custom engineered printed circuit board assemblies, emission monitors and instruments for industrial processes, and air filtration systems for industries and utilities.

Safe Harbor Statement

This press release contains forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date.